All articles by MarketLine
MarketLine
Johnson & Johnson splits into two as big pharma downsizes
The company’s decision to split is likely being made so it can focus on its fast-growing pharmaceutical and medical device units.
JD Health squares off to Alibaba in online healthcare with trading debut success
JD Health share price closed in green at 56% growth in the end of its first day of listing, which ended up with the company raising $3.5bn.
Climate change means fresh opportunities for pharmaceutical companies
225 of the world’s largest corporations highlighted roughly $2.1 trillion of possible opportunities to capitalise on climate change, including big pharma.